Univec, Inc.
UNVC - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.55M
Close$
$-0.00
222.2% downside
Current Fair Value
222.2% downsideOvervalued by 222.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5.55 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | 0.85 |
| Outstanding Shares | 2,523,096,680 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -4.56 |
|---|---|
| PEG | -334.98 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Univec, Inc.
3 employees
CEO: David Dalton
Univec, Inc. is a medical device firm that, through its various operating divisions, develops, licenses, and sells products across the United States and internationally. Its primary offerings include a range of auto-disable and safety sy...